References
- Mankodi A, Thornton CA. Myotonic syndromes. Curr Opin Neurol 2002;15:545–552.
- Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis 2000;21:361–370.
- Ylä-Herttuala S. Oxidized LDL and atherogenesis. Ann N Y Acad Sci 1999;874:134–137.
- Stadtman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000;899:191–208.
- Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000;29: 222–230.
- Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000;408:239–247.
- McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049–6055.
- Cotgreave IA, Moldeus P, Brattsand R, Hallberg A, Andersson CM, Engman L. Alpha-(phenylselenenyl)acetophenone derivatives with glutathione peroxidaselike activity: a comparison with ebselen. Biochem Pharmacol 1992;43:793–802.
- Armstrong RN. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 1997;10:2–18.
- van Bladeren PJ. Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 2000;129:61–76.
- Ihara Y, Mori A, Hayabara T, Namba R, Nobukuni K, Sato K, et al. Free radicals, lipid peroxides and antioxidants in blood of patients with myotonic dystrophy. J Neurol 1995;242:119–122.
- Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 1969;27:502–522.
- Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993:269:2386–91.
- Krystkowiak P, du Montcel ST, Vercueil L, Houeto JL, Lagrange C, Cornu P, et al. Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia. Mov Disord 2007:22:685–689.
- Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001;54:356–361.
- Moosmann B, Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert Opin Investig Drugs 2002;11: 1407–1435.
- Guentchev M, Siedlak SL, Jarius C, Tagliavini F, Castellani RJ, Perry G, et al. Oxidative damage to nucleic acids in human prion disease. Neurobiol Dis 2002;9:275–281.
- Pattee GL, Post GR, Gerber RE, Bennett JP. Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:90.
- Pitkanen S, Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 1996, 15:345–351.
- Rodriguez MC, Tarnopolsky MA. Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med 2003;34:1217–1220.
- Goldstein S. Human genetic disorders that feature premature onset and accelerated progression of biological aging. In: Schneider EL (ed.). The Genetics of Aging. New York: Plenum Press; 1978; 171–224.
- Babu GN, Kumar A, Chandra R, Puri SK, Singh RL, Kalita J, Misra UK. Oxidant–antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem Int 2008;52:1284–1289.
- Toscano A, Messina S, Campo GM, Dileo R, Musumeci O, Rodolico C, et al. Oxidative stress in myotonic dystrophy type 1. Free Radic Res 2005;39:771–776.
- Hunter MIS, Mohamed JB. Plasma antioxidants and lipid peroxidation products in Duchenne muscular dystrophy. Clin Chim Acta 1986;155:123–131.
- Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?Br J Pharmacol 2004;142:231–255.
- Imlay JA. Pathways of oxidative damage. Annu Rev Microbiol 2003;57:395–418.
- Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009;390:191–214.
- Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, et al. A general method for the detection of large CAG repeat expansion by fluorescent PCR. J Med Genet 1996;33:1022–1026.